NVS vs. KEN
NVS (Novartis AG) and KEN (Kenon Holdings Ltd.) are both stocks. NVS operates in Drug Manufacturers - General (Healthcare), while KEN operates in Utilities - Regulated Electric (Utilities). Over the past 10 years, NVS returned 11.14%/yr vs 41.88%/yr for KEN. At a 0.13 correlation, their price movements are largely independent.
Performance
NVS vs. KEN - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with NVS having a 14.40% return and KEN slightly lower at 14.26%. Over the past 10 years, NVS has underperformed KEN with an annualized return of 11.14%, while KEN has yielded a comparatively higher 41.88% annualized return.
NVS
- 1D
- -0.55%
- 1M
- 2.22%
- YTD
- 14.40%
- 6M
- 18.98%
- 1Y
- 30.60%
- 3Y*
- 19.57%
- 5Y*
- 14.77%
- 10Y*
- 11.14%
KEN
- 1D
- 0.54%
- 1M
- -20.01%
- YTD
- 14.26%
- 6M
- 23.62%
- 1Y
- 115.93%
- 3Y*
- 57.99%
- 5Y*
- 31.84%
- 10Y*
- 41.88%
NVS vs. KEN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 14.40% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
KEN Kenon Holdings Ltd. | 14.26% | 126.18% | 62.44% | -19.16% | -23.73% | 93.65% | 57.17% | 50.73% | 23.06% | 85.88% |
Correlation
The correlation between NVS and KEN is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jan 14, 2015 | 0.13 |
Fundamentals
NVS:
$293.28B
KEN:
$3.84B
NVS:
$6.99
KEN:
$1.54
NVS:
21.90
KEN:
46.98
NVS:
1.48
KEN:
7.89
NVS:
5.29
KEN:
3.80
NVS:
7.62
KEN:
2.56
NVS:
$56.05B
KEN:
$1.01B
NVS:
$42.19B
KEN:
$166.82M
NVS:
$22.40B
KEN:
$339.95M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVS vs. KEN — Risk / Return Rank
NVS
KEN
NVS vs. KEN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Kenon Holdings Ltd. (KEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVS | KEN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.49 | ||
| Sortino ratioReturn per unit of downside risk | -1.24 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.44 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 2.43 | 4.42 | -1.98 |
| Martin ratioReturn relative to average drawdown | 5.88 | 17.27 | -11.39 |
Loading charts...
Drawdowns
NVS vs. KEN - Drawdown Comparison
The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum KEN drawdown of -69.20%. Use the drawdown chart below to compare losses from any high point for NVS and KEN.
Loading charts...
Drawdown Indicators
| NVS | KEN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.10% | -69.20% | +27.10% |
Max Drawdown (1Y)Largest decline over 1 year | -12.65% | -26.41% | +13.76% |
Max Drawdown (3Y)Largest decline over 3 years | -19.95% | -32.27% | +12.32% |
Max Drawdown (5Y)Largest decline over 5 years | -20.42% | -69.20% | +48.78% |
Max Drawdown (10Y)Largest decline over 10 years | -26.03% | -69.20% | +43.17% |
Current DrawdownCurrent decline from peak | -6.46% | -24.16% | +17.70% |
Average DrawdownAverage peak-to-trough decline | -10.92% | -23.19% | +12.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.23% | 6.74% | -1.51% |
Volatility
NVS vs. KEN - Volatility Comparison
The current volatility for Novartis AG (NVS) is 7.18%, while Kenon Holdings Ltd. (KEN) has a volatility of 14.84%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than KEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVS | KEN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.18% | 14.84% | -7.66% |
Volatility (6M)Calculated over the trailing 6-month period | 14.96% | 30.71% | -15.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.02% | 39.55% | -18.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.89% | 39.79% | -20.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.64% | 41.93% | -22.29% |
Dividends
NVS vs. KEN - Dividend Comparison
NVS's dividend yield for the trailing twelve months is around 3.12%, less than KEN's 5.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KEN Kenon Holdings Ltd. | 5.31% | 7.24% | 11.18% | 11.46% | 25.00% | 7.35% | 7.41% | 5.75% | 96.34% | 0.00% | 0.00% | 45.52% |
NVS Novartis AG | 3.12% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
NVS vs. KEN - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and Kenon Holdings Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVS vs. KEN - Profitability Comparison
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.
KEN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kenon Holdings Ltd. reported a gross profit of 47.00M and revenue of 317.00M. Therefore, the gross margin over that period was 14.8%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.
KEN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kenon Holdings Ltd. reported an operating income of 4.00M and revenue of 317.00M, resulting in an operating margin of 1.3%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.
KEN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kenon Holdings Ltd. reported a net income of 26.00M and revenue of 317.00M, resulting in a net margin of 8.2%.
Frequently Asked Questions
NVS and KEN have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KEN has higher volatility (14.84%) compared to NVS (7.18%). In terms of maximum drawdown, NVS dropped -42.10% vs KEN's -69.20%.
KEN currently has the higher Sharpe Ratio (2.96 vs 1.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVS and KEN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer